首页> 外文期刊>Journal of Oncology Practice >Establishing a Minority-Based Community Clinical Oncology Program: The University of Medicine and Dentistry of New Jersey, New Jersey Medical School–University Hospital Cancer Center Experience
【24h】

Establishing a Minority-Based Community Clinical Oncology Program: The University of Medicine and Dentistry of New Jersey, New Jersey Medical School–University Hospital Cancer Center Experience

机译:建立基于少数群体的社区临床肿瘤学计划:新泽西州医科大学,新泽西医学院-大学医院癌症中心的经验

获取原文
           

摘要

AbstractThe authors present a guide to the necessary infrastructure and institutional support that must be in place before considering a program like the Minority-Based Community Clinical Oncology Program.The Minority-Based Community Clinical Oncology Program (MB-CCOP) at University of Medicine and Dentistry of New Jersey, New Jersey Medical School–University Hospital Cancer Center was established to serve an unmet need in a medically, educationally, and socioeconomically underserved community of primarily African American and Latino patients in Newark and Essex County, New Jersey. The MB-CCOP was built on an existing infrastructure of multidisciplinary teams of cancer specialists who collaborated in patient care and an existing clinical research program, which included multilingual staff and a breast cancer navigator. This article highlights some of the unique opportunities and challenges involved in the startup of an MB-CCOP specifically relevant to an academic setting. We present a guide to the necessary infrastructure and institutional support that must be in place before considering such a program and some of the steps an institution can take to overcome barriers preventing successful enrollment of patients onto clinical trials.
机译:摘要作者提出了有关必要的基础设施和机构支持的指南,在考虑诸如基于少数族裔的社区临床肿瘤学计划之类的计划之前,必须提供适当的基础设施和机构支持。医学与牙科大学的基于少数族裔的社区临床肿瘤学计划(MB-CCOP)在新泽西州纽瓦克市和埃塞克斯县,主要由非裔美国人和拉丁裔患者组成的医疗,教育和社会经济服务不足的社区,成立了新泽西医学院,大学医院癌症中心新泽西分校。 MB-CCOP建立在现有的由癌症专家的多学科团队组成的基础架构上,他们在患者护理方面进行了合作,并且现有的临床研究计划包括会说多种语言的人员和一名乳腺癌导航员。本文着重介绍了与学术环境特别相关的MB-CCOP启动所涉及的一些独特机遇和挑战。我们提供了有关在考虑此类计划之前必须具备的必要基础设施和机构支持的指南,以及机构可以采取的一些步骤来克服阻碍成功将患者纳入临床试验的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号